SOLEORARE
LIVE

Serial Number

99126168

Owner

Soleo Health Holdings, Inc.

Attorney

Daniel P. Mullarkey

Filing Date

Apr 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SOLEORARE Trademark

Serial Number: 99126168

SOLEORARE is a trademark filed by Soleo Health Holdings, Inc. on April 8, 2025. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Soleo Health Holdings, Inc. (23 trademarks)

Frisco, TX 75034

Entity Type: 03

Trademark Details

Filing Date

April 8, 2025

Registration Date

Not Registered

Published for Opposition

July 1, 2025

Goods & Services

Providing information in the field of drug specific education for prescribers, patients and the pharmaceutical industry by means of a call center regarding rare, ultra-rare, and orphan medications and therapies

Providing information in the field of financial support options and resources for prescribers, patients and the pharmaceutical industry by means of a call center; Providing information in the field of health insurance verification and authorization for prescribers, patients and the pharmaceutical industry by means of a call center regarding rare, ultra-rare, and orphan medications and therapies

Providing information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry by means of a call center regarding rare, ultra-rare, and orphan medications and therapies; Specialty pharmacy services in the field of rare, ultra-rare, and orphan medications and therapies

Providing information in the field of adherence and compliance to prescribed medication dosing regimens and disease state for prescribers, patients and the pharmaceutical industry by means of a call center; Medical services, namely, providing home infusion services, specialty infusion services and ambulatory infusion services utilizing rare, ultra-rare, and orphan medications and therapies

Filing History

TEAS STATEMENT OF USE RECEIVED
May 18, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2026 EXRA
SOU EXTENSION 1 GRANTED
Feb 11, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 11, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 11, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 26, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 8, 2025 MAFR
NEW APPLICATION ENTERED
Apr 8, 2025 NWAP